baber/WOPTO huggingface dataset:
Patent NZ-547752-A (NZ)
Title: Heterocyclic boronic acid compounds for inhibiting dipeptidyl peptidase-IV
Inventor: CAMPBELL DAVID ALAN
IPC: C07D403/12
Filed: 2004-11-12
Abstract: Disclosed is a compound of formula (I), or a cyclic isomer thereof of formula (Vb), or an enantiomer, diastereomer, solvate, or hydrate thereof, wherein n is 1 to 3, X is CH2, S, O, CF2, or C(CH3)2, the ring including X may optionally contain a double bond, Z may be a substituent as described or a fused cyclopropyl, and wherein the other substituents are as described in the specification. Also disclosed is the use of the compound for inhibiting dipeptyl peptidase-IV, and for treating conditions regulated or normalized by inhibition of dipeptyl peptidase-IV, such as impaired glycemic control and diabetes.
Patent NZ-547839-A (NZ)
Title: Polymer composite gloves having fibrous coating on dipped rubber
Inventor: LUCAS DAVID MARC
IPC: B32B25/02
Filed: 2004-04-06
Abstract: Disclosed is an elastomeric article comprising: a first layer, the first layer comprising a natural or synthetic polymer; and a second layer bonded to the first layer comprising a polymer composite fibrous coating, the polymer composite fibrous coating comprising at least one elastomer, a flock of fibers and a micronised wax.
Patent NZ-552428-A (NZ)
Title: Water storage evaporation control using floating modular units which self ballast
Inventor: CAP GEORGE JAROSLAV
IPC: B65D88/34
Filed: 2005-07-27
Abstract: A floating modular cover for a water storage is disclosed. The cover consists of a plurality of modules in which each module includes an upper surface (35), a lower surface and a chamber defined by the upper surface and lower surfaces. Openings in the lower surface allow water into the chamber provide ballast for each module. Openings in the upper surface allow air to flow into and out of the chamber depending on the water level within the chamber. Each module has flotation means (33) to ensure that each module floats. Each module is formed from upper and lower sections (32) having complementary mating faces. Each module's upper and lower surfaces are also functionally identical so it does not matter which way up the modules are.
Patent NZ-553357-A (NZ)
Title: Force control strut
Inventor: ADOLINE JACK W
Filed: 2007-02-22
Abstract: A force control strut comprising an elongated housing having a straight guide tube with an inner surface, a rod member having an inner end reciprocally movable along the guide tube and an outer end extending outwardly from the housing, a guide member secured into the first end of the housing to form a bushing allowing reciprocation of the rod member between a retracted position and an extended position and a bottom plug fixed to the second end of the housing. A guide piston is secured to the inner end of the rod and is slidable along the inner surface of the housing. A coil spring is located between the piston and one end of the housing to bias the rod in a given direction in the housing. There is a damper mechanism combined with the movable rod and including a plunger reciprocally mounted in an elongated force controlling passageway inside the rod. The plunger is movable outwardly from the rod and has a distal end engageable with the bottom plug to force the plunger intro the force controlling passageway to dampen movement of the rod in the housing.
Patent NZ-555534-A (NZ)
Title: Solid particles from controlled destabilisation of microemulsions
Inventor: KONG LINGGEN
Filed: 2005-11-15
Abstract: Disclosed is a process for making a particulate substance comprising: - providing an emulsion comprising droplets dispersed in a continuous liquid phase, wherein at least some of the droplets comprise nuclei; and - at least partly destabilising the droplets to form the particulate substance, said particulate substance comprising a plurality of particles.
Patent NZ-556778-A (NZ)
Title: Method for the production of wine and wine obtained from such a method
Inventor: VILLA ADALBERTO
IPC: A23L27/00
Filed: 2007-07-27
Abstract: Disclosed is a method for the production of wine comprising the steps of: a) preparing a grape must; b) subjecting said grape must to clarification; and c) subjecting said clarified grape must to alcoholic fermentation to obtain said wine; characterized in that it comprises the step of adding to said clarified grape must, in sequence 1) at least one tannin and 2) a lysozyme.
Patent NZ-564092-A (NZ)
Title: TWEAK binding antibodies
Inventor: BURKLY LINDA C
IPC: A61K39/395
Filed: 2006-05-25
Abstract: Disclosed is an isolated protein comprising an immunoglobulin heavy chain variable domain sequence and an immunoglobulin light chain variable domain sequence that can form an antigen binding site that binds to human TNF-like weak inducer of apoptosis ('TWEAK'), wherein the protein has one or more of the following properties: (a) the protein competes for binding to human TWEAK with one or more of the group consisting of: (i) an antibody comprising a heavy chain variable domain of SEQ ID NO:50 and a light chain variable domain of SEQ ID NO:51; (ii) an antibody having a heavy chain of SEQ ID NO:64 and a light chain of SEQ ID NO:66; and (iii) an antibody having a heavy chain of SEQ ID NO:64 and a light chain of SEQ ID NO:68; (b) the protein binds to an epitope on human TWEAK that overlaps with the epitope bound by the antibody according to anyone of (a)(i) to (iii); (c) the heavy and/or light chain variable domain sequence is encoded by a nucleic acid that hybridizes under high stringency conditions to the complement of a nucleic acid encoding the antibody according to anyone of (a)(i) to (iii); (d) the heavy and/or light chain variable domain sequence is at least 80% identical to the amino acid sequence of the corresponding variable domain of the antibody according to anyone of (a)(i) to (iii); (e) the heavy and light chain variable domain sequences are collectively at least 95% identical in the complementarity determining regions ('CDRs') to the CDRs of the heavy and light chain variable domains of the antibody according to anyone of (a)(i) to (iii); or (f) the heavy and light chain variable domain sequences are collectively at least 95% identical in the framework regions to the framework regions of the heavy and light chain variable domains of the antibody according to anyone of (a)(i) to (iii).
Patent NZ-565952-A (NZ)
Title: A plastic floor tile having tongues on two sides and slots fot tongues on the other to interconnect the tiles
Inventor: BLACKIE PAUL
IPC: E01C5/20
Filed: 2008-01-08
Abstract: A demountable floor tile (1) is disclosed. The tile has a tongue (4) extending along one side of a complementary tongue receiving channel (5 - Fig 4) extending along the opposite side for receipt of a tongue of an adjacent floor tile. The floor tread surface (2) of the tile (1) between the tongue and the channel is provided with two rows of rectangular block parts (6) each separated by central longitudinally extending channel (9) and each separated from the respective adjacent tongue or by channel by respective longitudinal side channels (7, 8). The tile has laterally extending strengthening flanges (10) extending between a wall defining the tongue channel and being greater in number than two. The tile also has laterally extending further flanges (11) extending in the central channel (9) between the two block parts (6) and being greater in number than two
Patent NZ-573965-A (NZ)
Title: 4-indol-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system
Inventor: ZEMOLKA SASKIA
IPC: C07D209/14
Filed: 2007-07-17
Abstract: Disclosed are 4-indol substituted 1-aminocyclohexane derivatives as represented by the general formula (I), wherein A represents N or CR7-10, wherein A represents N at most twice; W represents O, S or NR4 with the proviso that if W represents O or S, A denotes CR7-10; one of the radicals B or C represents H or optionally substituted alkyl; and the other radical B or C represents a 4-amino-4-(alkyl/phenyl or heteroaryl)-cyclohexyl derivative; and wherein the remaining substituents are as defined herein. Also disclosed are compounds such as 2-(4-(dimethylamino)-4-phenylcyclohex-1-enyl)-3-benzyl-1H-indole hydrochloride and 1-butyl-4-(5-fluoro-3-(2-(piperidin-1-yl)ethyl)-1H-indol-2-yl)-N,N-dimethyl-cyclohexanamine citrate. Further disclosed is a medicament which contains at least one compound as defined above, optionally in the form of a racemate, of pure stereoisomers, in the form of an acid or of a base or in the form of a salt, or in the form of a solvate, and optionally containing one or more additives and/or one or more auxiliary substances and/or one or more optionally further active compounds for the treatment of conditions such as stress, depression, epilepsy, Alzheimer's disease, senile dementia, catalepsy, general cognitive dysfunctions, learning and memory disorders, withdrawal symptoms, alcohol and/or drug and/or medicament abuse and/or dependency, sexual dysfunctions, cardiovascular diseases, hypotension, hypertension, tinnitus, pruritus, migraine, impaired hearing, lack of intestinal motility, impaired food intake, anorexia, obesity, locomotor disorders, diarrhoea etc.
Patent NZ-574874-A (NZ)
Title: Biological organism identification product and methods
Inventor: FISCHER GERALD W
IPC: C12Q1/68
Filed: 2007-09-10
Abstract: A method for detecting whether a microbe specific nucleic acid sequence is present in a biological sample, comprising the steps of: 1. Providing an aqueous composition in pre-mixed form; wherein the composition consists essentially of a mix containing components sufficient for a polymerase chain reaction (PCR) which include: - Forward and reverse amplification primers specific for PCR amplification of the nucleic acid sequence; - A PCR polymerase enzyme; - One or more buffers; - A plurality of nucleotides sufficient for PCR amplification of the nucleotide sequence; - A detectable probe for detection of the nucleic acid sequence after PCR amplification; and - The mix of combined components remains substantially stable for at least two weeks when maintained at a temperature of between 18 to 27 degrees celcius. 2. Extracting nucleic acid from a biological sample; 3. Adding the extracted nucleic acid to the pre-mixed aqueous composition; 4. Subjecting the pre-mixed composition and added nucleic acid to PCR amplification under conditions where the nucleic acid sequence for detection may be amplified; and 5. Assaying the composition to detect the presence of the amplified nucleic acid sequence.
Patent NZ-577408-A (NZ)
Title: A latch and latchset
Inventor: WOOD DAVID ANDREW
IPC: E05B57/00
Filed: 2009-06-04
Abstract: Disclosed is a latchset which includes a latch apparatus and a strike. The apparatus has a latch which rotates about a pivot between a latched position and an unlatched position, and a handle which moves between an extended position at which the handle projects at least partly from the assembly and a retracted position at which the handle is at least partly withdrawn into the assembly. Movement of the handle to the retracted position causes the latch to move to the latched position.
Patent NZ-577977-A (NZ)
Title: Mask
Inventor: NOZAKI SATOSHI
IPC: A41D13/11
Filed: 2009-06-26
Abstract: A mask comprising a covering sheet portion for covering a mouth and a nose of a face and retaining sheet portions extending rearwardly from right and left sides, respectively, of the covering sheet portion, each retaining sheet portion having an opening for hanging on an ear, the covering sheet portion is air-permeable and capable of being deformed into a forwardly projecting three-dimensional shape as applied to the face, while the retaining sheet portion is stretchable, wherein the covering sheet portion and the individual retaining sheet portions are integrally made of a stretchable nonwoven fabric and a non-stretchable nonwoven fabric is laid on and bonded to an inner side of the covering sheet portion.
Patent NZ-579341-A (NZ)
Title: Compositions comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases
Inventor: WOODHEAD STEVEN JOHN
IPC: A61K31/415
Filed: 2008-03-14
Abstract: Disclosed herein is the compound (S) 2-amino-1-(4-chloro-phenyl)-1-[4-(1H-pyrazol-4-yl)-phenyl]-ethanol, composition comprising said compound, wherein the composition is either substantially free of (R) 2-amino-1-(4-chloro-phenyl)-1-[4-(1H-pyrazol-4-yl)-phenyl]-ethanol or the composition contains a mixture of the (S) and (R) enantiomers in which the (S) enantiomer predominates. Said compounds are useful for inhibiting or modulating the activity of protein kinase B(PKB), protein kinase A (PKA), ROCK kinase or p70S6K kinase and so therefore are useful in treating a disease or condition such as abnormal cell growth or abnormal arrested cell death, carcinoma of the bladder, breast, colon kidney, epidermal, liver, lung, oesophagus, gall bladder, ovary, pancreas, stomach, cervix, endometrium, thyroid, prostate or skin, a hematopoietic tumour of lymphoid lineage, a hematopoietic tumour of myeloid lineage, thyroid follicular cancer, a tumour of mesenchymal origin, a tumour of the central or peripheral nervous system, melanoma, seminoma, teratocarcinoma, osteosarcoma, xeroderma pigmentosum, keratoctanthoma, thyroid follicular cancer, or Kaposi's sarcoma.
Patent NZ-579689-A (NZ)
Title: Solid forms of (e) -1- (4- ( (ir, 2s, 3r) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl) ethanone oxime
Inventor: WU WENXUE
IPC: A61P29/00
Filed: 2008-04-11
Abstract: Disclosed is a crystalline form of (E)-1-(4-((1R-,2S, 3R)-1,2,3,4-tetrahydrohydroxybutyl)-1H-imidazol-2-yl)-ethanone oxide for the treatment of rheumatoid arthritis, type 1 diabetes or uveitis.
Patent NZ-588406-A (NZ)
Title: An assay comprising determining levels of biomarkers including ca125 and at least one selected from agr-2, midkine and crp for detecting a gynecological condition
Inventor: AUTELITANO DOMINIC J
IPC: G16B40/00
Filed: 2009-04-21
Abstract: Disclosed is an assay for determining the presence or absence of ovarian cancer in a subject, said assay comprising determining levels of a panel of biomarkers in a biological sample from said subject relative to a control, said panel of biomarkers comprising cancer antigen 125 (CA125), C-reactive protein (CRP), serum amyloid A (SAA), interleukin-6 (IL-6) and interleukin-8 (IL-8) and subjecting the levels to multivariate analysis to generate an algorithm which provides a single index of probability, compared to the control, of the presence or absence of the ovarian cancer.
Patent NZ-590806-A (NZ)
Title: Microbicidal composition comprising N-methyl-1,2-benzisothiazolin-3-one and cocamidopropyl-N-2-hydroxyethylcarbamoyl methyl dimethyl ammonium chloride
Inventor: ASHMORE JOHN WILLIAM
IPC: A01N31/02
Filed: 2008-07-08
Abstract: Disclosed herein is a microbicidal composition comprising: (a) N-methyl-1,2-benzisothiazolin-3-one; and (b) cocamidopropyl-N-2-hydroxyethylcarbamoyl methyl dimethyl ammonium chloride, wherein the ratio of cocamidopropyl-N-2-hydroxyethylcarbamoyl methyl dimethyl ammonium chloride to N-methyl-1,2-benzisothiazolin-3-one is from 1:188 to 1:0.0022.The microbicidal compositions disclosed herein can be used to inhibit the growth of microorganisms or higher forms of aquatic life (such as protozoans, invertebrates, bryozoans, dinoflagellates, crustaceans, mollusks, etc.)
Patent NZ-592164-A (NZ)
Title: Method and system for item identification
Inventor: SANNIER GAEL
IPC: G06V10/50
Filed: 2009-10-13
Abstract: 592164 Disclosed is a method for identifying an item (11) by a use of a digital image processing unit (13).The unit (13) selects at least one zone of a digital image of the item (11) and for each zone selected, establishes a corresponding histogram of colour values of the pixels of the zone. For each bin of each histogram established, the unit (13) compares the number of pixels with corresponding minimum and maximum reference values of a reference data set associated to a reference item. From this, the unit (13) determines whether the number of pixels is comprised between the reference values. The item (11) is then identified as corresponding to the reference item if the number of pixels is comprised between the reference values for at least N of the bins (with N being greater or equal to 1) of at least one zone.
Patent NZ-593124-A (NZ)
Title: Method and Apparatus for raising a sunken concrete slab
Inventor: BURRELL CRAIG ANTHONY
IPC: E01C23/10
Filed: 2011-05-27
Abstract: A method of adjusting a slab of material wherein the slab has an underside at least partially in contact with ground below the slab, the method including the steps of: a) forming a hole through the slab; b) forming a cavity under the hole and beneath the slab in the vicinity of the hole; c) forming a first bearing surface below the cavity and hole by inserting a first load bearing material into or onto the ground; d) locating a spacer on the first bearing surface such that a portion of the spacer is directly beneath the hole and a portion of the spacer is directly beneath the underside of the slab; e) inserting a second load bearing material into the cavity around the spacer to form a second bearing surface in proximity to the underside of the slab; f) locating a lifting device within the spacer and directly below the underside of the slab; and g) operating the lifting device to adjust the slab.
Patent NZ-594996-A (NZ)
Title: Cholestanol derivative for combined use
Inventor: YAZAWA SHIN
IPC: A61K33/243
Filed: 2009-09-03
Abstract: 594996 Disclosed is the use of the combination of a cholestanol derivative represented by formula (1) (wherein G represents GlcNAc-Gal- or GlcNAc-) or a cyclodextrin inclusion compound thereof, and irinotecan in the manufacture of a medicament for the treatment of cancer.
Patent NZ-595662-A (NZ)
Title: Auxotrophic, recombinant bcg strain pasteur and use thereof for combating human infections caused by parasites
Inventor: TENDLER MIRIAM
IPC: A61P31/06
Filed: 2010-03-10
Abstract: Disclosed is a recombinant BCG vaccine strain of Mycobacterium bovis that expresses the Sm14 antigen of Schistosoma mansoni (BCGr Pasteur ?LeuD/p?K410-hsp60*-Sm14). The vaccine strain according to the present invention is used for combating infection by parasites, particularly Schistosoma mansoni. The vaccine strain is a leucine-auxotrophic strain derived from the BCG substrain Pasteur, supplemented for leucine after genetic transformation with the construct p?K410-hsp60*-SM14. The effectiveness of the BCGr Pasteur ?LeuD/p?K410-hsp60*-Sm14 strain for combating Schistosoma mansoni infection by expressing the recombinant Sm14 antigen in vivo is demonstrated in the present invention.
Patent NZ-597836-A (NZ)
Title: Production of acid soluble soy protein isolates (”s700”)
Inventor: SCHWEIZER MARTIN
IPC: A23L2/02
Filed: 2010-06-30
Abstract: 597836 Disclosed is a method of producing a soy protein product with a protein content of at least 60 wt% (N x 6.25) d.b., which includes: extracting a soy protein source with an aqueous salt solution optionally containing an antioxidant, at a temperature of at least 1°C to cause solubilization of soy protein in the soy protein source and to form an aqueous protein solution having a protein content of 5 to 50 g/L and a pH of 1.5 to 11, separating the aqueous protein solution from residual soy protein source, adding calcium salt solution to the aqueous protein solution to a conductivity of 15 to 85 mS to cause a precipitate to form in the concentrated protein solution, removing the precipitate from the concentrated protein solution, diluting the clarified concentrated protein solution into 2 to 20 volumes of water having a temperature of 2° to 90°C, acidifying the resulting solution to a pH of 1.5 to 4.4 to produce an acidified clear protein solution, increasing the concentration of the acidified clear protein solution to 50 to 300 g/L while maintaining the ionic strength substantially constant by using a selective membrane technique, using a membrane having a molecular weight cut-off of 3,000 to 1,000,000 Daltons to provide a second concentrated protein solution.
Patent NZ-598115-A (NZ)
Title: A bifurcated clip for a concrete reinforcement
Inventor: ANDERSEN BRENDAN
IPC: E04C5/00
Filed: 2012-02-08
Abstract: A clip 12 for concrete reinforcement comprises a pair of opposed resilient clipping arms 18 separated by a central web 30 such that a separate clipping section 12a, 12b is defined between a respective one of the arms 18 and the central web 30. Each clipping arm 18 has at an outer end an inwardly projecting flange. The flange is engageable by a reinforcing rod 10 upon insertion into the clipping section 12a, 12b. The configuration of the clip 12 is such that a rod inserted into the clipping section 12a, 12b will cause outwards deflection of the arm 18 and outwards deflection of the inner flange relative to the arm 18.
Patent NZ-598791-A (NZ)
Title: Anti-gcc antibody molecules and related compositions and methods
Inventor: NAM SAMUEL S
IPC: A61K39/395
Filed: 2010-10-22
Abstract: Disclosed is an anti-GCC antibody, comprising a light chain and a heavy chain, with sequence identities as disclosed in the specification. Also disclosed are methods of treating disorders such as cancer by use of the said antibody.
Patent NZ-599044-A (NZ)
Title: Testing device for identifying antigens and antibodies in biofluids
Inventor: GARNIER GIL
IPC: A61B5/00
Filed: 2010-09-24
Abstract: A method and a testing device for identifying an antigen or antibody within a biofluid sample are disclosed. The testing device comprises a substrate formed of cellulosic material and having a hydrophilic microfluidic channel pattern thereon. The hydrophilic microfluidic channel pattern defins a collection zone, and at least one detection zone extending therefrom (81, 82, 83). The detection zone has an antibody or antigen immobilised therein. The biofluid sample can be deposited on the collection zone and transferred by capillary action to the detection zone and when the antigen or antibody in the biofluid sample reacts with a corresponding said antibody or antigen within the detection zone a visual indication on the detection zone results from reduced wicking and/or differentiation of eluation speeds.
Patent NZ-599545-A (NZ)
Title: Stable S-(+)-abscisic acid liquid and soluble granule formulations
Inventor: WANG YUEH
IPC: A01N35/00
Filed: 2008-01-30
Abstract: 599545 Disclosed is a soluble 2-cis, 4-trans-(S)-abscisic acid granule formulation comprising: a) 2-cis, 4-trans-(S)-abscisic acid powder; b) a lactose powder or a sucrose powder; c) a sodium dioctyl sulfosuccinate wetting agent; and d) a binder.